TY - JOUR
T1 - Membrane-depolarizing channel blockers induce selective glioma cell death by impairing nutrient transport and unfolded protein/amino acid responses.
AU - Niklasson, Mia
AU - Maddalo, Ianluca
AU - Sramkova, Zuzana
AU - Mutlu, Ercan
AU - Wee, Shimei
AU - Sekyrova, Petra
AU - Schmidt, Linnéa
AU - Fritz, Nicolas
AU - Dehnisch, Ivar
AU - Kyriatzis, Gregorios
AU - Krafcikova, Michaela
AU - Carson, Brittany B.
AU - Feenstra, Jennifer M.
AU - Marinescu, Voichita D.
AU - Segerman, Anna
AU - Haraldsson, Martin
AU - Gustavsson, Anna Lena
AU - Hammarström, Jars G J
AU - Jenmalm Jensen, Annika
AU - Uhrbom, Lene
AU - Altelaar, A. F Maarten
AU - Linnarsson, Sten
AU - Uhlén, Per
AU - Trantirek, Lukas
AU - Vincent, C. Theresa
AU - Nelander, Sven
AU - Enger, Per Oyvind
AU - Andang, Michael
PY - 2017/4/1
Y1 - 2017/4/1
N2 - Glioma-initiating cells (GIC) are considered the underlying cause of recurrences of aggressive glioblastomas, replenishing the tumor population and undermining the efficacy of conventional chemotherapy. Here we report the discovery that inhibiting T-type voltage-gated Ca2+ and KCa channels can effectively induce selective cell death of GIC and increase host survival in an orthotopic mouse model of human glioma. At present, the precise cellular pathways affected by the drugs affecting these channels are unknown. However, using cell-based assays and integrated proteomics, phosphoproteomics, and transcriptomics analyses, we identified the downstreamsignaling events these drugs affect. Changes in plasma membrane depolarization and elevated intracellular Na+, which compromised Na+-dependent nutrient transport, were documented. Deficits in nutrient deficit acted in turn to trigger the unfolded protein response and the amino acid response, leading ultimately to nutrient starvation and GIC cell death. Our results suggest new therapeutic targets to attack aggressive gliomas.
AB - Glioma-initiating cells (GIC) are considered the underlying cause of recurrences of aggressive glioblastomas, replenishing the tumor population and undermining the efficacy of conventional chemotherapy. Here we report the discovery that inhibiting T-type voltage-gated Ca2+ and KCa channels can effectively induce selective cell death of GIC and increase host survival in an orthotopic mouse model of human glioma. At present, the precise cellular pathways affected by the drugs affecting these channels are unknown. However, using cell-based assays and integrated proteomics, phosphoproteomics, and transcriptomics analyses, we identified the downstreamsignaling events these drugs affect. Changes in plasma membrane depolarization and elevated intracellular Na+, which compromised Na+-dependent nutrient transport, were documented. Deficits in nutrient deficit acted in turn to trigger the unfolded protein response and the amino acid response, leading ultimately to nutrient starvation and GIC cell death. Our results suggest new therapeutic targets to attack aggressive gliomas.
UR - http://www.scopus.com/inward/record.url?scp=85017401273&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-16-2274
DO - 10.1158/0008-5472.CAN-16-2274
M3 - Article
AN - SCOPUS:85017401273
SN - 0008-5472
VL - 77
SP - 1741
EP - 1752
JO - Cancer Research
JF - Cancer Research
IS - 7
ER -